Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPP.L Regulatory News (OPP)

  • There is currently no data for OPP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule 1 - Origo Sino-India Plc

27 Nov 2009 09:51

RNS Number : 1940D
AIM
27 November 2009
 



ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Origo Sino-India plc

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

4th Floor

One Circular Road

Douglas

Isle of Man

IM99 3NZ

COUNTRY OF INCORPORATION:

Isle of Man

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.origoplc.com

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY) IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

The merger of Origo Resource Partners plc and Origo Sino-India plc (the "Company") is considered reverse take-over under AIM Rule 14.

Investing policy

The Company invests predominately in privately held companies across various sectors of

China's economy, and in companies and assets with connections to the Chinese market, with the Company's objective being to provide shareholders with above market returns, primarily through capital appreciation.

In terms of stage, the Company generally pursues three kinds of opportunities:

• investments in pre-IPO opportunities, where the Company can add value through providing assistance in relation to restructuring, international expansion and the listing on a domestic or foreign stock exchange;

• profitable, expansion stage companies requiring financing to meet working capital requirements, expansion capital and/or as capital to finance merger and acquisition opportunities; and

• selected earlier-stage companies, which demonstrate compelling prospects for fast-growth and paths to profitability.

At its present level of capitalisation, the Company is unlikely to commit in excess of $20 million to any single investee company at the time of investment. For early-stage opportunities, initial commitments may be less than $1 million. While the Company does not have any set gearing policy (although it does not expect to be highly geared at an enlarged group level) investee companies, directly or indirectly, may themselves have outstanding borrowings. The Company currently carries out its own commercial due diligence in respect of potential investments (and engages professional advisers for specialised tasks such as legal, financial and technical due diligence) but may outsource this process over time.

In addition to investing predominately in privately held companies, the Company may, in its absolute discretion, hold or invest in publicly traded shares, quasi-equity and/or debt instruments, including convertible or non-convertible debt securities coupled with warrants and/or options, which may or may not represent shareholding or management control. The Company plans to allocate no more than 20 per cent. of available cash resources to investment in publicly traded equities.

The Company seeks to be an active investor and to make minority investments. To the extent possible, minority investments are structured so as to ensure adequate minority protection rights, including but not limited to board participation (via a board director/observer), membership of supervisory, audit and oversight committees, as well as specific veto rights over key corporate decisions.  In addition, the Company generally dedicates at least one other nominee who, together with the board director/observer, is responsible for assisting the investee company on matters such as building and augmenting the management team, implementing relevant corporate governance and financial control procedures, defining and executing a growth and financing strategy, introducing suitable partners and business opportunities and matters related to future fund-raisings, acquisitions or exit considerations.

The holding period for investments is expected to vary depending on the type of investment, the particular circumstances of the relevant investee company, and the intended exit route. The holding period for pre-IPO and expansion stage investments is targeted at between 9 and 24 months and for earlier stage investments at between 24 and 48 months. There is currently a limited spread of investments but this may change if the Company raises additional debt or equity capital.

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Ordinary Shares of £0.0001 each. Number of shares - TBC

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLEAND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

No capital to be raised; anticipated market capitalisation - TBC

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

TBC

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIESADMITTED OR TRADED:

None

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Chris Andre Rynning (Chief Executive Officer)

Karl Niklas Ponnert (Chief Financial Officer)

Wang Chao Yong (Executive Chairman)

Christopher Martin Jemmett (Non-Executive Director)

Dipankar Basu (Non-Executive Director)

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Currently

GLG Partners LP - 29.59%

British Steel Pensions - 5.51%

Origo Sino-India Employee Benefit Trust - 5.23%

Merrill Lynch 5.10%

Bullfrog Holdings Limited 4.97%

Nortrust Nominees Limited 4.70%

Progressive Asset Management - 4.16%

Wellington Management Company - 3.58%

After Admission

TBC

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

Each of the following persons being consultants and contractors to the Company has received those fees detailed below from the Company within the 12 months prior to 10 November 2009

Aura Financial LLP 

Capita Registrars Limited 

City Continental Finance 

Dougherty Quinn Limited 

Jiayou International Holdings Ltd 

Jonathan Leslie 

Salzer Consulting Pte Ltd 

Seymour Pierce Limited 

Sinohigh Investment Corporation 

Summit Global Holdings Limited 

ANTICIPATED ACCOUNTING REFERENCE DATE 

DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

(i) 31 December

(ii) 30 June 2009

(iii) 30 June 2010, 30 September 2010 and 30 June 2011

EXPECTED ADMISSION DATE:

14 December 2009

NAME AND ADDRESS OF NOMINATED ADVISER:

Smith & Williamson Corporate Finance Limited

25 Moorgate

London

EC2R 6AY

NAME AND ADDRESS OF BROKER:

Liberum Capital Limited

CityPoint

10th Floor

One Ropemaker Street

London

EC2Y 9HT

OTHER THAN IN THE CASE OF A QUOTED APPLICANTDETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

Smith & Williamson Corporate Finance Limited

25 Moorgate

London

EC2R 6AY

DATE OF NOTIFICATION:

27 November 2009

NEW/ UPDATE:

New

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PAAGCBDBCSDGGCR
Date   Source Headline
30th May 20227:00 amRNSCancellation - Origo Partners Plc
27th May 20226:00 pmRNSOrigo Partners
28th Apr 20227:30 amRNSSuspension – Origo Partners plc
26th Apr 20227:00 amRNSSuspension from Trading
7th Mar 20227:00 amRNSAsset Sale Update
2nd Feb 20227:00 amRNSReturn of Capital and Asset Sale
27th Jan 20223:16 pmRNSAsset Sale
24th Dec 202110:46 amRNSResult of AGM
6th Dec 20213:34 pmRNSNotice of AGM
3rd Dec 20217:00 amRNSInvestment Update
22nd Sep 20217:00 amRNSHalf-year Report
28th Jun 20217:00 amRNSAnnual Financial Report
4th Jun 20217:00 amRNSSale of Shares in Gobi Coal & Energy Ltd
14th May 202111:18 amRNSHolding(s) in Company
9th Mar 202112:20 pmRNSHolding(s) in Company
8th Mar 20217:00 amRNSStatement re share price movement
24th Feb 20214:27 pmRNSHolding(s) in Company
23rd Feb 20219:53 amRNSHolding(s) in Company
27th Jan 20218:38 amRNSUpdate re Website
22nd Jan 202110:03 amRNSUpdate re Remaining Assets
24th Dec 202011:20 amRNSResult of AGM
24th Dec 202010:14 amRNSHolding(s) in Company
24th Dec 20209:51 amRNSHolding(s) in Company
17th Dec 202012:38 pmRNSHolding(s) in Company
30th Nov 20204:30 pmRNSNotice of AGM
28th Sep 20207:00 amRNSHalf-year Report
23rd Sep 20207:09 amRNSPrice Monitoring Extension
23rd Sep 20207:02 amRNSSecond Price Monitoring Extn
22nd Sep 20202:06 pmRNSSecond Price Monitoring Extn
22nd Sep 20202:01 pmRNSPrice Monitoring Extension
30th Jun 20207:00 amRNSAnnual Financial Report
12th Jun 20207:00 amRNSInvestment update
20th May 202011:00 amRNSHolding(s) in Company
7th May 20207:00 amRNSUpdate RE: Liquidation Plans
29th Apr 20202:06 pmRNSSecond Price Monitoring Extn
29th Apr 20202:02 pmRNSPrice Monitoring Extension
17th Mar 202012:12 pmRNSChange of Registered Office & Update on Website
12th Mar 20203:32 pmRNSWebsite
4th Feb 20207:00 amRNSInvestment Update
24th Dec 20197:00 amRNSInvestors update
11th Nov 201911:33 amRNSHolding(s) in Company
30th Oct 20194:16 pmRNSResult of AGM
23rd Oct 201910:41 amRNSHolding(s) in Company
23rd Oct 201910:39 amRNSHolding(s) in Company
4th Oct 20194:23 pmRNSNotice of AGM
27th Sep 20194:25 pmRNSReplacement Capital Distribution
27th Sep 201911:05 amRNSReplacement Interim Unaudited Financial Statements
27th Sep 20197:05 amRNSCapital Distribution
27th Sep 20197:00 amRNSInterim Unaudited Financial Statements
28th Jun 20194:15 pmRNSPosting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.